Company Press Releases
12/21/11 PerkinElmer’s ViaCord®Cord Blood Banking Business to Collaborates with Mirical Babies to Improve Collection of Stem Cells from Premature Births for Potential Therapeutic Use
10/12/11 PerkinElmer’s ViaCord®Cord Blood Banking Business to Expand Stem Cell Harvesting Capabilites
3/30/11 PerkinElmer’s ViaCord® Family Cord Blood Banking Business Announces First and Only Service to Bank Stem Cells Harvested from Umbilical Cord Tissue
1/31/11 PerkinElmer’s ViaCord Releases 200th Umbilical Cord Blood Unit for Stem Cell Treatment
1/22/09 PerkinElmer’s ViaCord Research Institute™ to support diabetes research effort at University of Massachusetts Medical School
1/16/09 PerkinElmer’s ViaCord Research Institute™ and M.D. Anderson Cancer Center extend collaboration to study cord blood stem cell expansion system in adult transplantation.
8/11/08 PerkinElmer’s ViaCord Teams up with Mia Hamm to Promote Cord Blood Education and Assist Transplant Families
11/15/07 PerkinElmer completes acquisition of ViaCell
11/9/07 PerkinElmer announces successful completion of cash tender offer for ViaCell
10/12/07 PerkinElmer commences cash tender offer for ViaCell
10/1/07 PerkinElmer to expand genetic screening business through acquisition of ViaCell
9/18/07 ViaCell Announces Expansion of ViaCord Processing Laboratory
7/9/07 ViaCell Prevails Over PharmaStem in Federal Circuit Patent Appeal
6/13/07 ViaCord and Children’s Hospital Oakland Research Institute Announce 100th Cord Blood Transplant
1/08/07 Novel Unrestricted Somatic Stem Cells (USSCs) offer potential medical breakthrough
1/08/07 ViaCell Implements Automation Technology at ViaCord Processing Laboratory
5/30/06 ViaCell Announces New Office Actions Rejecting PharmaStem Patent Claims
5/30/06 ViaCell and Children’s Hospital Oakland Research Institute Expand Sibling Cord Blood Donor Program
4/25/06 First FDA Clearance of Sterile Field Cord Blood Collection Bag
3/16/06 ViaCell Reports Encouraging Preclinical Findings of Unrestricted Somatic Stem Cells from Cord Blood
12/6/04 Federal Court in Delaware reverses jury's judgment completely and rules in favor of ViaCell and against PharmaStem